February 10th, 2022
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
January 24th, 2022
Collaboration with NTT Research to advance computational neurobiology
Joint research project at Harvard Center for Brain Science examines animal behavior to inform AI
November 15th, 2021
A mammoth solution
Scientists look to extinct genes to protect endangered species, climate
October 15th, 2021
Harvard University and Resilience announce five-year R&D alliance to incubate new technologies, launch companies to advance the manufacture of complex medicines
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
October 14th, 2021
Chemists’ dye method holds promise for long-term data storage
Harvard has licensed the technology to a new digital data storage company founded by members of the lab
